What is the global market size of Automated External Defibrillators Market?

Global Automated External Defibrillator Market size was valued at USD 17 billion in 2022 and is poised to grow from USD 18.8 billion in 2023 to USD 39.1 billion by 2031, at a CAGR of 11% in the forecast period (2024-2031).

Automated External Defibrillators Market Size

Automated External Defibrillators Market Insights

Global Automated External Defibrillators Market size was valued at USD 1.4 billion in 2023 and is poised to grow from USD 1.5 billion in 2024 to USD 2.62 billion by 2032, growing at a CAGR of 7.2% during the forecast period (2025-2032).

Automatic external defibrillators are life-saving tools that help correct irregular heart rhythms. The primary drivers propelling the growth of the automated electronic defibrillator market are the increasing incidence of cardiac disorders, the ageing population, and technological developments in the industry, which are bolstered by expanding investments from industry participants. Automatic defibrillators are machines that automatically monitor cardiac rhythm and, if an abnormality is found, shock the patient with electricity to return their heartbeat to normal. AEDs are deployed in many places (such as hospitals and airports) due to their portability and simplicity of use. They are crucial in expanding the window of opportunity for life-saving defibrillation.

Over the course of the projected period, the market for automated external defibrillators is anticipated to grow profitably due to the rising prevalence of cardiovascular disorders and the growing introduction of sophisticated automated external defibrillators. However, during the course of the projected period, factors including strict restrictions, a lack of awareness regarding sudden cardiac arrest, and a lack of early remedial actions may impede the growth of the analyzed market. The prevalence of cardiovascular disorders is rising, the population is ageing quickly, and automated defibrillator technology developments are the main reasons propelling the market expansion. Also, the market is growing as public access defibrillators are becoming more important. On the other hand, growing pricing pressure on market players limits market expansion.

FAQs

Intense competition among major competitors vying for market supremacy characterises the competitive environment of the global automated external defibrillator market. Global firms with broad product portfolios and business alliances, such Philips Healthcare, ZOLL Medical Corporation, and Stryker Corporation, control large market shares. In this crucial medical device industry, up-and-coming companies like Physio-Control and Cardiac Science Corporation are also making noteworthy progress, encouraging innovation and boosting competitiveness. 'Nihon Kohden Corporation (Japan) ', 'Asahi Kasei Medical Co., Ltd (Japan) ', 'Koninklijke Philips N.V. (Netherlands) ', 'Biotronik (Germany) ', 'GE Healthcare (US) ', 'Schiller AG (Switzerland) ', 'Stryker Corporation (US) ', 'Mindray Medical International Limited (China) ', 'Metrax GmbH (Germany) ', 'Boston Scientific Corporation (US) ', 'CU Medical Systems Inc. (South Korea) ', 'Philips Healthcare (Netherlands)'

With an electric shock to the heart, the automated external defibrillator can help restore abnormal cardiac rhythms, which is why it is becoming more and more popular. In the upcoming years, it is anticipated that the worldwide market for automated external defibrillators will offer revenue-generating potential due to the rising use of this device in the treatment of patients experiencing sudden cardiac arrest. Additionally, a rise in the number of smokers and alcohol addicts could open profitable business prospects.

Uprising in Automated External Defibrillators: Technology is advancing quickly in the industry. Artificial intelligence (AI), cloud connectivity, and smart features are just a few examples of how AEDs are being improved in terms of usability, accuracy, and connectivity to improve patient outcomes and enable remote monitoring.

The US and Canada make up the two largest segments of the North American market for automated external defibrillators. The largest market for automated external defibrillators is the United States. The market is primarily driven by a large population with diabetes, a significant growth in respiratory disorders, and a growing public awareness of respiratory diseases. For automated external defibrillators, the United States is expected to be the largest market because of several factors, including a rise in the prevalence of cardiovascular disease (CVDs). The market for automated external defibrillators is growing at the fastest rate in Asia Pacific as factors such increased rates of cardiovascular disease, developing healthcare systems, and government programmes that encourage public access to these life-saving equipment. Elevated adoption rates in the region can also be attributed to increased awareness and training initiatives.